Scholarly Index
Christopher J. Logothetis
The University of Texas MD Anderson Cancer Center; 84,042 total citations; 687 total publications; best world rank #26
The University of Texas MD Anderson Cancer Center
84,042Total citations
687Total publications
119H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Prostate Cancer Treatment and Research | Lifetime | 26 | US 18 | 99.84 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 66 | US 38 | 99.38 |
| Cancer, Lipids, and Metabolism | Lifetime | 91 | US 48 | 99.50 |
| Testicular diseases and treatments | Lifetime | 40 | US 15 | 99.28 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 134 | US 86 | 99.30 |
| Bone health and treatments | Lifetime | 184 | US 88 | 99.02 |
| Urinary and Genital Oncology Studies | Lifetime | 176 | US 103 | 98.75 |
| Cancer Diagnosis and Treatment | Lifetime | 371 | US 185 | 98.02 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 365 | US 185 | 98.84 |
| Cancer Research and Treatments | Lifetime | 635 | US 348 | 96.95 |
| Sarcoma Diagnosis and Treatment | Lifetime | 829 | US 401 | 97.28 |
| Urologic and reproductive health conditions | Lifetime | 353 | US 191 | 97.83 |
| Cancer Treatment and Pharmacology | Lifetime | 915 | US 441 | 97.61 |
| Multiple Myeloma Research and Treatments | Lifetime | 557 | US 254 | 97.24 |
| Multiple and Secondary Primary Cancers | Lifetime | 870 | US 376 | 92.29 |
| Prostate Cancer Treatment and Research | 2021-2025 | 595 | US 209 | 94.90 |